A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In

See also
Status	Clinical Trial	Phase
Terminated	`NCT00524030` - Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures	Phase 3
Completed	`NCT00143143` - Pregabalin Open-Label Extension Trial in Patients With Partial Seizures	Phase 3
Completed	`NCT00771927` - Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures	N/A
Completed	`NCT00236873` - A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.	Phase 2
Completed	`NCT01745952` - Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS)	N/A
Completed	`NCT00772603` - Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures	Phase 3
Completed	`NCT00280696` - A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures	Phase 3
Completed	`NCT00643136` - A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures	Phase 3
Completed	`NCT00230698` - A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure	Phase 3
Completed	`NCT00072813` - MRI in Autosomal Dominant Partial Epilepsy With Auditory Features	N/A
Enrolling by invitation	`NCT04309812` - Transcranial Direct Current to Treat Epilepsy at Home	Early Phase 1
Withdrawn	`NCT00422110` - A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures	Phase 2/Phase 3
Completed	`NCT00620555` - A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures	Phase 3
Completed	`NCT00448916` - Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures	Phase 3
Completed	`NCT00210522` - An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy	Phase 2
Completed	`NCT00236886` - Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients	Phase 3
Completed	`NCT00236860` - A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures	Phase 2
Active, not recruiting	`NCT03689114` - Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)	Phase 4
Completed	`NCT01098162` - Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug	N/A
Completed	`NCT05273398` - Effects of Diazepam on RNS Detections	Phase 4

NCT number	NCT00603473
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 3
Start date	January 2008
Completion date	December 2009

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms